Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 103,138 | 76,256 | 36,655 | 5,624 | 0 |
| Cost of Goods | 4,756 | 3,407 | 2,039 | 543 | N/A |
| Gross Profit | 98,382 | 72,849 | 34,616 | 5,081 | N/A |
| Operating Expenses | 85,833 | 83,573 | 52,994 | 46,291 | 68,423 |
| Operating Income | 13,305 | -10,317 | -18,339 | -40,667 | -68,423 |
| Interest Expense | 6,822 | 10,195 | 10,317 | 9,882 | 1,757 |
| Other Income | 5,399 | 3,954 | 3,100 | 7,837 | 359 |
| Pre-tax Income | 11,882 | -16,558 | -25,556 | -42,712 | -69,821 |
| Income Tax | -39 | -239 | 8,271 | 250 | 1,014 |
| Net Income Continuous | 11,921 | -16,319 | -33,827 | -42,962 | -70,835 |
| Net Income | $11,921 | $-16,319 | $-33,827 | $-42,962 | $-70,835 |
| EPS Basic Total Ops | 0.14 | -0.19 | -0.38 | -0.56 | -0.87 |
| EPS Basic Continuous Ops | 0.14 | -0.19 | -0.41 | -0.53 | -0.87 |
| EPS Diluted Total Ops | 0.13 | -0.19 | -0.38 | -0.56 | -0.87 |
| EPS Diluted Continuous Ops | 0.13 | -0.19 | -0.41 | -0.53 | -0.87 |
| EPS Diluted Before Non-Recurring Items | 0.13 | 0.27 | -0.40 | -0.56 | -0.88 |
| EBITDA(a) | $14,290 | $-9,368 | $-17,553 | $-39,909 | $-67,950 |